- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06665984
Greater Houston Area Pediatric Bipolar Registry (GHAPBR)
February 13, 2026 updated by: Jair Soares, The University of Texas Health Science Center, Houston
The purpose of this study is to perform a comprehensive research assessment of children and adolescents who meet The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria for Bipolar Disorder (BD) , offspring of a parent with BD, and healthy controls (HC), to obtain blood samples and saliva samples from each subject to allow the evaluation for BD biomarkers and genetic information, to notify participants about future research studies they may qualify for , to recommend follow-up with an outpatient provider if needed and to use magnetic resonance imaging (MRI) (structural MRI and diffusion tensor imaging) to investigate brain structures and relevant pathways associated with mood and behavioral regulation, conversion from softer forms of the BD spectrum (BD-NOS) to harder forms (BD-I and BD-II) and possible early identification.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
1000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jair C Soares, M.D. PhD
- Phone Number: (713) 486-6663
- Email: utmooddisorders@uth.tmc.edu
Study Contact Backup
- Name: Courtney Vecera
- Phone Number: (713) 486-6663
- Email: utmooddisorders@uth.tmc.edu
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77479
- Recruiting
- The University of Texas Health Science Center at Houston
-
Contact:
- Jair C Soares, M.D. PhD
- Phone Number: (713) 486-6663
- Email: utmooddisorders@uth.tmc.edu
-
Contact:
- Courtney Vecera
- Phone Number: (713) 486-6663
- Email: utmooddisorders@uth.tmc.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Subjects will be recruited from the Harris County Psychiatric Center, Harris Center for Mental Health, Texana Behavioral Healthcare Clinic, and UT Child and Adolescent Outpatient Psychiatry Clinic at Behavioral Science Campus, community referrals, referrals from other health providers, as well as self-referrals.
Description
Inclusion Criteria for bipolar patients or offspring of bipolar parents:
- Any current mood state (in the case of bipolar subjects)
- For bipolar patients: DSM-V criteria for BD type I, BD type II, or BD NOS, as per the administration of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)
- For the offspring of bipolar parents: at least one parent meeting DSM-V criteria for BD type I or BD type II, or BD NOS as per the administration of the MINI Adult
Exclusion Criteria for bipolar patients or offspring of bipolar parents:
- Autism Spectrum Disorder (ASD)
- Developmental Intellectual Disorder
- Severe Neurological Disorder that affects cognitive status (e.g., epilepsy, traumatic brain injury, tubular sclerosis)
- Schizophrenia
- Uncontrolled or severe medical problem per investigator judgment
- For the offspring: parents with a history of any brain diseases, including seizures, stroke, meningitis, encephalitis, dementia, and other degenerative brain diseases; parents with a history of intellectual disability
Exclusion Criteria for healthy control subjects:
- Any Psychiatric Diagnosis
- Any family history of Bipolar Disorder, Psychotic Disorder, Schizophrenia, or Schizoaffective disorder in a first-degree relative
- Any family history of a neurological condition in a first-degree relative.
- Mental Retardation/Intellectual Disability
- Severe Neurological Disorder that affects cognitive status (e.g., epilepsy, traumatic brain injury, tubular sclerosis)
- Schizophrenia
- Uncontrolled or severe medical problem per investigator judgement
Exclusion criteria for annual visits:
- Autism Spectrum Disorders (ASD)
- Intellectual Developmental Disorder
- Severe Neurological Disorder that affects cognitive status (e.g., epilepsy, traumatic brain injury, tubular sclerosis)
- Schizophrenia
- Uncontrolled or severe medical problem per investigator judgement
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Healthy Control Subjects
|
|
Bipolar Patients
|
|
Offspring of Bipolar Parents
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Positive Identification of Bipolar Disorder as Assessed by Mini-International Neuropsychiatric Interview for Children and Adolescents (MINI Kid 7.2) (child)
Time Frame: baseline, annually until participant turns 25 years of age
|
baseline, annually until participant turns 25 years of age
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jair C Soares, M.D. PhD, The University of Texas Health Science Center, Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 6, 2022
Primary Completion (Estimated)
December 6, 2027
Study Completion (Estimated)
December 6, 2046
Study Registration Dates
First Submitted
August 4, 2023
First Submitted That Met QC Criteria
October 28, 2024
First Posted (Actual)
October 30, 2024
Study Record Updates
Last Update Posted (Actual)
February 18, 2026
Last Update Submitted That Met QC Criteria
February 13, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-MS-20-0329
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Bipolar Disorder
-
Massachusetts General HospitalTerminatedPediatric Bipolar Disorder | Pediatric OCDUnited States
-
Bradley HospitalNational Institute of Mental Health (NIMH)UnknownBipolar Disorder | Pediatric Bipolar Disorder | Childhood-onset Bipolar DisorderUnited States
-
Massachusetts General HospitalRecruitingPediatric Bipolar DisorderUnited States
-
Massachusetts General HospitalTerminatedPediatric Bipolar DisorderUnited States
-
Massachusetts General HospitalTerminatedPediatric Bipolar DisorderUnited States
-
Mayo ClinicNational Institutes of Health (NIH)CompletedOmega-3 Fatty Acids | Pediatric Bipolar Disorder | Adolescent Bipolar Disorder | Magnetic Resonance Spectroscopy ImagingUnited States
-
Organon and CoCompleted
-
Vielight Inc.Not yet recruitingBipolar Disorder (BD) | Bipolar | Bipolar Disorder DepressionCanada
-
ProgenaBiomeWithdrawnBipolar Disorder | Bipolar I Disorder | Bipolar II Disorder | Bipolar Type I Disorder | Bipolar Disorder Mild | Bipolar Disorder Moderate | Bipolar Disorder SevereUnited States
-
University of Texas Southwestern Medical CenterThe Texas Child Mental Health Care Consortium (TCMHCC)RecruitingBipolar Disorder Family Members | Bipolar Disorder (BD) | Bipolar Disorder I or II | Screening ToolUnited States